First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...

Podcaster Joe Rogan has claimed on The Joe Rogan Experience that using red light therapy and vitamin supplements has improved ...

No changes in protocol recommended for LUGANO and LUCIA clinical trials –– Masked safety data continues to show no safety signals, consistent ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

Older age in adults with diabetic macular edema (DME) appears to be associated with less robust visual and anatomic gains from anti-vascular endothelial growth factor (VEGF) therapy, according to ...

The gene therapy will utilize the firm's suprachoroidal vector coAAV-SCS, which it says will be an effective and less burdensome treatment alternative.

In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...

Millions of Americans are or will experience some form of macular degeneration, which reduces central vision. This can make ...

The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...

A wireless retinal implant called PRIMA is changing that reality by helping blind patients read and recognize faces again.

Coave Therapeutics SA has nominated a lead gene therapy program, CoTx-101, for the treatment of retinal vascular diseases, ...

Background/Aims Major age-related ocular diseases (ARODs)—glaucoma, degeneration of macula and posterior pole (DMPP) and ...